Conavi Medical Corp.
CNVIF
Rang in Aktien
#32984
Conavi Medical Corp. is a medical technology firm that specializes in... Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Aktienkurs
$0.091975
Marktkapitalisierung
$7.85M
Veränderung (1 Tag)
-5.26%
Veränderung (1 Jahr)
-88.75%
Land
CA
Handel Conavi Medical Corp. (CNVIF)
Kategorie
Healthcare
EPS für Conavi Medical Corp. (CNVIF)
EPS zum June 2024 TTM: $-0.04
Laut den aktuellen Finanzberichten und dem Aktienkurs von Conavi Medical Corp. beträgt das aktuelle EPS des Unternehmens (TTM) $-0.04. Am Ende des Jahres 2022 betrug das EPS $-0.37 eine Steigerung gegenüber dem EPS von 2021, das $-0.14 betrug.
EPS-Verlauf von Conavi Medical Corp. von 2016 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $-0.04 | -174.83% |
| 2023 | $0.06 | -116.38% |
| 2022 | $-0.37 | 164.29% |
| 2021 | $-0.14 | -63.16% |
| 2020 | $-0.38 | -72.86% |
| 2019 | $-1.40 | 8.53% |
| 2018 | $-1.29 | -70.68% |
| 2017 | $-4.40 | -6.78% |
| 2016 | $-4.72 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| $3.11 | -7,026.50% |
US
|
|
| $3.59 | -8,095.55% |
IE
|
|
| $9.73 | -21,770.38% |
US
|
|
| $2.48 | -5,623.39% |
US
|
|
| - | - |
DE
|
